Tadalafil Tablet
Product Images NDC 13668-581

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 13668-581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 01)

FDA Label Image

Figure 1 (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 02)

The text shows a graph depicting the mean change from baseline in meters for placebo and tadalafil 40 mg. The x-axis shows the meters, and the y-axis depicts the number of subjects. The graph indicates that tadalafil 40 mg had a statistically significant improvement compared to placebo.*

FDA Label Image

Figure 2 (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 03)

This text appears to be a table with data related to a clinical study on the treatment of pulmonary arterial hypertension (PAH) using the drug tadalafil. The table indicates different study parameters such as the number of subjects, their demographics (age and gender), PAH etiology, baseline 6-minute walk distance, and baseline WHO functional class. The table also includes the change in 6-minute walk distance for subjects treated with tadalafil compared to placebo, along with 95% confidence intervals. The usefulness of the data depends on the context and purpose for which it is being evaluated.*

FDA Label Image

Figure 3 (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 04)

This appears to be a graph comparing the percentage of patients without clinical worsening over time between a group taking tadalafil (at 20mg and 40mg doses) and a placebo group. The x-axis is labeled as "Time to Clinical Worsening in Days" and the y-axis appears to show the percentage of patients without clinical worsening, with values ranging from 0% to 100%.*

FDA Label Image

Logo (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 05)

FDA Label Image

Logo (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 06)

FDA Label Image

Container Label (A7bacee2 C3dd 45c4 8c75 0f51661a51f3 07)

This appears to be an output of a medication packaging or label. The text includes information such as the name of the medication (Tadalafil), dosage instructions, manufacturer (Torrent Pharmaceuticals), and a product code (NOC 13668-581-30). However, the text is not fully readable and contains errors, making it difficult to interpret the full meaning and context.*

FDA Label Image

Figure 1

FDA Label Image

Figure 2

This text appears to be a chart showing the effects of various drugs on the absorption of Tadalafil. It includes information such as the drug administered, whether it is a CYP3A inhibitor or inducer, and how it affects the AUC and Emax of Tadalafil. The chart also includes conclusions and recommendations regarding dose adjustment and whether to avoid certain drugs.*

FDA Label Image

Figure 3

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.